Eurofins Scientific Sa (ERFSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | 06-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 855,146 | 664,301 | 733,584 | 748,451 | 512,682 |
| Marketable Securities | 908 | 2,164 | 4,092 | 6,870 | 5,900 |
| Receivables | 1,339,309 | 1,294,300 | 1,293,465 | 1,283,510 | 1,252,625 |
| Inventories | 165,626 | 153,550 | 153,351 | 163,887 | 153,404 |
| Other current assets | 372,005 | 539,211 | 629,771 | 615,857 | 512,682 |
| TOTAL | $2,972,862 | $2,653,526 | $2,814,263 | $2,818,575 | $2,437,293 |
| Non-Current Assets | |||||
| PPE Net | 2,766,937 | 5,881,322 | N/A | N/A | 4,990,587 |
| Investments And Advances | 124,077 | 127,039 | 91,321 | 87,668 | 88,081 |
| Intangibles | 6,024,393 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 128,732 | 6,231,599 | 6,093,854 | 5,937,773 | 5,814,712 |
| TOTAL | $9,044,139 | $12,239,960 | $6,185,175 | $6,025,441 | $10,893,380 |
| Total Assets | $12,017,110 | $11,782,340 | $11,627,500 | $11,250,640 | $10,623,980 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 611,192 | 518,110 | 183,719 | 158,871 | 225,260 |
| Accounts payable and accrued liabilities | 687,137 | 698,928 | 634,079 | 615,858 | 682,417 |
| Other current liabilities | 1,040,070 | 1,028,103 | 1,142,052 | 1,164,329 | 923,059 |
| TOTAL | $2,367,346 | $2,283,448 | $1,983,542 | $1,964,683 | $1,867,190 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,058,681 | 3,388,596 | 3,632,922 | 3,411,752 | 3,278,593 |
| Other Non-Current Liabilities | 174,821 | 164,912 | 180,919 | 207,830 | 226,419 |
| TOTAL | $4,346,681 | $3,671,998 | $3,939,838 | $3,760,026 | $3,645,773 |
| Total Liabilities | $6,713,910 | $5,955,554 | $5,923,273 | $5,724,818 | $5,512,962 |
| Shareholders' Equity | |||||
| Common Shares | 2,043 | 2,056 | 2,046 | 2,072 | 2,002 |
| Retained earnings | 3,190,026 | 2,913,230 | 2,690,312 | 2,464,631 | 2,458,049 |
| Other shareholders' equity | 2,364,131 | 3,244,498 | 3,104,873 | 3,111,117 | 2,665,963 |
| TOTAL | $5,303,200 | $5,826,784 | $5,704,231 | $5,525,820 | $5,111,014 |
| Total Liabilities And Equity | $12,017,110 | $11,782,338 | $11,627,504 | $11,250,638 | $10,623,976 |